Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
08/2000
08/16/2000EP1027441A2 Murine dna molecules encoding polypeptides having kinase functions
08/16/2000EP1027440A1 Inhibitor protein of the wnt signal pathway
08/16/2000EP1027437A1 Wnt-1 induced secreted polypeptides: wisp-1, -2 and -3
08/16/2000EP1027432A2 RIBOZYMES TARGETED TO IL-15 mRNA
08/16/2000EP1027431A2 April- a novel protein with growth effects
08/16/2000EP1027430A1 64 human secreted proteins
08/16/2000EP1027429A1 Jnk3 modulators and methods of use
08/16/2000EP1027426A1 A method of improved mixing of a varicella-infected cell culture in roller bottles
08/16/2000EP1027425A1 A method of improved mixing in roller bottles
08/16/2000EP1027424A1 Regulators of ucp3 gene expression
08/16/2000EP1027418A1 Cleaning compositions containing multiply-substituted protease variants
08/16/2000EP1027375A1 Anti-idiotypic monoclonal antibodies, their use in the active immunotherapy of malignant tumors, and compositions containing them
08/16/2000EP1027075A1 Gene therapy for stimulation of angiogenesis
08/16/2000EP1027063A1 Mannose receptor bearing cell line and antigen composition
08/16/2000EP1027027A2 Therapeutic method
08/16/2000EP1027014A1 Implantable system with drug-eluting cells for on-demand local drug delivery
08/16/2000EP1026941A1 Nepovirus resistance in grapevine
08/16/2000EP0795606B1 Process for producing transformed cell
08/16/2000EP0753015B1 Monoclonal antibodies recognizing tie-receptor and their use
08/16/2000EP0644929B1 System and method for transplantation of cells
08/16/2000CN1263598A Antibodies and SCFV immunotoxins specific to imported fire ants, and their application
08/16/2000CN1263556A Anti-GPIIB/IIIA recombinant antibodies
08/16/2000CN1263555A Human TOLL-like receptor proteins, related reagents and methods
08/16/2000CN1055501C Recombinant avipox virus, culture of cells infected by this virus and vaccines for poultry derived from this virus
08/15/2000US6103877 Purified antibody which specifically binds to human hypermethylated in cancer-1 polypeptide of specific amino acid sequence or its immunoreactive fragments; for diagnosis/ prognosis of cell proliferative disorders such as cancer
08/15/2000US6103874 Human KDEL receptor
08/15/2000US6103869 Isolated polypeptide with a mutation at amino acid 464, 465, and/or 467 resulting in dominant negative inhibition of transforming growth factor-beta signaling; therapy and diagnosis of related diseases
08/15/2000US6103692 Administering to said mammal, or contacting said cells with, a compound which inhibits lipid-dependent direct binding of a non-effector loop domain of ras with a raf zinc finger domain
08/15/2000US6103530 Medium for proliferating central nervous system stem cells includes standard basal medium; a carbohydrate; insulin, transferrin, progesterone, selenium, and/or putrescine; cell growth factors; and leukemia inhibitory factor
08/15/2000US6103529 Animal cell culture media comprising peptides derived from rice
08/15/2000US6103528 Reversible gelling culture media for in-vitro cell culture in three-dimensional matrices
08/15/2000US6103527 Nucleotide sequence from gene expressed in proliferating endothelial cells; for controlled gene expression especially for transgenic tissues and gene therapy
08/15/2000US6103526 Insect cell line, atcc crl-12579; use in recombinant baculovirus expression systems for production of proteins such as erythropoietin, neuraminidase, cd4, thrombospondin, carcinoembryonic antigen, and influenza hemagglutinin
08/15/2000US6103523 At least 70% undifferentiated, pluripotent cells obtainable by isolating an inner cell mass of a 5.5 day postcoitus blastocyst and culturing inner cell mass in feeder cells in rabbit medium; for production of chimeric rabbits
08/15/2000US6103522 Human marrow stromal cell lines which sustain hematopoiesis
08/15/2000US6103513 Novel proteolytic enzyme; for the treatment of immune, proliferative and degratory defects
08/15/2000US6103501 Recombinant protein which can be utilized as agonist or antagonist to its native cellular counterparts
08/15/2000US6103495 Direct expression of peptides into culture media
08/15/2000US6103494 Nucleotide sequences which code protein associated with immmune response; for the detection of flea allergy dermatitis; for the detection of modulators of immune response
08/15/2000US6103491 Methods and compositions for identifying morphogen analogs
08/15/2000US6103255 Porous polymer scaffolds for tissue engineering
08/15/2000US6103244 Containing a heterologous insert encoding an immunogenic protein, wherein said insert was molecularly cloned directly into the viral genome into a unique restriction endonuclease cleavage site
08/15/2000US6103237 More stable to purification than wild type mature hk2 polypeptide.
08/15/2000US6103234 Antibody to an inflammatory cytokine, said inflammatory cytokine comprising a mature macrophage inflammatory protein -2 (mmip-2)
08/15/2000US6102690 Bioethanol production from cellobiose; microorganism which expresses pyruvate decarboxylase, alcohol dehydrogenase, Klebsiella phospho-beta-glucosidase and Klebsiella (phosphoenolpyruvate-dependent phosphotransferase system) cellobiose-utilizing Enzyme II
08/15/2000CA2196431C Icam-4 materials and methods
08/15/2000CA2058930C Media for cell growth and method for making them
08/15/2000CA2046601C Production and use of anthelmintic agents and protective immunogens
08/11/2000CA2260376A1 New metalloproteases of the neprilysin family
08/10/2000WO2000046599A1 System for producing morphological and functional changes in adult mammalian cells
08/10/2000WO2000046585A2 Method for enriching or depleting tumour cells obtained from a body fluid and kit suitable for this purpose
08/10/2000WO2000046407A2 Methods of utilizing the tt virus
08/10/2000WO2000046391A2 Genes displaying enhanced expression during cellular senescence and terminal cell differentiation and uses thereof
08/10/2000WO2000046386A2 Gene repair involving the induction of double-stranded dna cleavage at a chromosomal target site
08/10/2000WO2000046385A1 Gene repair involving in vivo excision of targeting dna
08/10/2000WO2000046383A2 Method of modulating metabolite biosynthesis in recombinant cells
08/10/2000WO2000046378A2 Method of improving the primary energy metabolism of mammalian cell lines
08/10/2000WO2000046375A2 Methods for producing polypeptides in fungal cells
08/10/2000WO2000046374A1 $i(candida albicans) srb-7
08/10/2000WO2000046360A1 Improved helper dependent vector system for gene therapy
08/10/2000WO2000046353A1 Sebocytes, sebocyte cell lines and applications thereof
08/10/2000WO2000046352A1 Human t cell effectors expressing cd86 molecule and therapeutic use thereof
08/10/2000WO2000046351A2 Platform for the differentiation of cells
08/10/2000WO2000046350A1 Production of biomedical peptides and proteins in plants using transcomplementation systems
08/10/2000WO2000046349A1 Method and apparatus for maintenance and expansion of hemopoietic stem cells and/or progenitor cells
08/10/2000WO2000046348A1 Method for inducing differentiation into adipocytes, compound regulating differentiation into adipocytes and method for screening the same
08/10/2000WO2000046346A1 1-deoxy-d-xylulose-5-phosphate reductoisomerases, and methods of use
08/10/2000WO2000046344A2 Non-stochastic generation of genetic vaccines and enzymes
08/10/2000WO2000046251A2 Human polyclonal antibodies from transgenic nonhuman animals
08/10/2000WO2000046240A2 Polypeptides involved in immune response
08/10/2000WO2000046236A2 Novel rgs-containing molecules and uses thereof
08/10/2000WO2000046233A1 Pigment protein from coral tissue
08/10/2000WO2000045835A1 Vascular endothelial growth factor-2
08/10/2000WO2000045827A1 Cell composition containing macrophages, presenting anti-infectious and hematopoietic properties, and a process for preparing the same
08/10/2000WO2000045633A1 Transgenic animal showing vascular tissue-specific expression of angiotensin ii2 receptor
08/10/2000WO2000026239A3 $i(chlamydia) antigens and corresponding dna fragments and uses thereof
08/10/2000WO2000024937A3 Parallel methods for genomic analysis
08/10/2000WO2000024911A3 Human phospholipases
08/10/2000WO2000024866A3 Multipotential human medullary stromal cell line of and uses thereof
08/10/2000WO2000024773A3 Inhibition of transglutaminase-mediated microbial infection of a mammalian host
08/10/2000WO2000022097A3 Periferal blood mensenchymal precursor cells
08/10/2000WO2000012715A9 Modification of plant fibres
08/10/2000WO2000010588A9 Epidermal growth factor receptor antagonists for treating hypersecretion of mucus in the lungs
08/10/2000WO1999008706A8 Recombinant porcine adenovirus vector
08/10/2000DE19905069A1 Nucleinsäuremoleküle codierend Alternansucrase Nucleic acid molecules encoding alternansucrase
08/10/2000DE19904794A1 Verfahren zur Verbesserung des Primärstoffwechsels von Säugerzelllinien A method for improving the primary metabolism of mammalian cell lines
08/10/2000DE19904785A1 Verfahren zur Herstellung von stabilem Alginatmaterial Process for the preparation of stable alginate
08/10/2000DE19904267A1 Verfahren zur Anreicherung von Tumorzellen aus einer Körperflüssigkeit und dazu geeigneter Kit A process for the enrichment of tumor cells from a body fluid and to a suitable kit
08/10/2000DE19903920A1 Sebozyten, Sebozyten-Zellinie und deren Verwendungen Sebocytes, sebocytes cell line and their uses
08/10/2000CA2362239A1 Novel rgs-containing molecules and uses thereof
08/10/2000CA2362126A1 B7rp-1 polypeptides
08/10/2000CA2361678A1 Method of modulating metabolite biosynthesis in recombinant cells
08/10/2000CA2361615A1 The use of vascular endothelial growth factor 2 antagonist in the treatment of an injury to or disorder of an eye
08/10/2000CA2361599A1 Methods of utilizing the tt virus
08/10/2000CA2361191A1 Gene repair involving the induction of double-stranded dna cleavage at a chromosomal target site
08/10/2000CA2361038A1 Pigment protein from coral tissue
08/10/2000CA2360878A1 Gene repair involving excision of targeting dna
08/10/2000CA2360834A1 Candida albicans srb-7
08/10/2000CA2360796A1 Improved helper dependent vector system for gene therapy
08/10/2000CA2360753A1 Method of improving the primary energy metabolism of mammalian cell lines
1 ... 1488 1489 1490 1491 1492 1493 1494 1495 1496 1497 1498 1499 1500 1501 1502 1503 1504 1505 1506 1507 1508 ... 1827